NMC Approves 589 PG Medical Seats Across 27 Colleges After Appeal Review, Boosting Specialist Training Capacity

Spread the Message

Read Time:4 Minute, 42 Second

New Delhi, January 5, 2026: The National Medical Commission (NMC) has sanctioned a total of 589 postgraduate (PG) medical seats in 27 medical colleges following a review by its First Appeal Committee, incorporating 171 additional seats granted after appeals against initial assessments. This decision, announced via public notice on December 31, 2025, ensures these seats can be immediately included in the ongoing NEET PG 2025-26 counselling process without awaiting formal Letters of Permission (LOPs). The move addresses appeals filed under Section 28(5) of the NMC Act, 2019, by institutions challenging decisions from the Medical Assessment and Rating Board (MARB).

Key Developments and Seat Breakdown

The First Appeal Committee, which met on December 22 and 23, 2025, examined appeals from medical colleges seeking increases in PG intake for the 2025-26 academic year. While initial MARB approvals provided a baseline, the appeals resulted in 171 extra seats across various specialties, bringing the total to 589 in the listed institutions. High-demand fields saw significant gains: MD General Medicine now totals 144 seats, MD Radio-Diagnosis 110 seats, MS General Surgery 63 seats, and MD Anaesthesiology 109 seats.nmc+1

Specialty	Additional Seats Approved	Total Seats After Approval
MD – Anaesthesiology	24	109
MD – General Medicine	30	144
MD – Radio Diagnosis	30	110
MS – General Surgery	17	63
MS – Obstetrics & Gynaecology	14	33
MD – Paediatrics	17	43
MD – Dermatology, Venereology & Leprosy	8	23

Less common specialties like MD Anatomy and MD Community Medicine each received 2 seats, while MD Emergency Medicine gained 8. The 27 colleges span 10 states and union territories, including Uttar Pradesh (e.g., Autonomous State Medical College, Faizabad), Tamil Nadu (e.g., Saveetha Medical College), Maharashtra (e.g., Krishna Institute of Medical Sciences), and remote areas like Arunachal Pradesh (TomoRiba Institute).

Expert Commentary

Dr. Rishi Kumar, a senior public health consultant formerly with the Ministry of Health and Family Welfare, who was not involved in the review, described the decision as “a pragmatic step toward expanding specialist workforce without compromising standards.” He noted, “India faces a dire shortage of specialists—only about 1 per 10,000 people in many fields like radiology and anaesthesiology—making these seats vital for bridging gaps in rural and underserved areas.” Similarly, Dr. Priya Sharma, Dean of a private medical college in Delhi NCR, emphasized the appeal process’s role: “It allows institutions to demonstrate compliance post-assessment, ensuring quality while maximizing capacity.”

NMC Director of PG MARB, Sukh Lal Meena, stated in the notice: “The list of seats granted by the First Appeal Committee is attached herewith for the information of all stakeholders,” underscoring transparency. Counselling authorities have been directed to treat the published list as valid for admissions, streamlining the NEET PG process managed by the Medical Counselling Committee (MCC).

Background and Context

India’s PG medical education has expanded rapidly under NMC oversight, with total seats rising from 49,884 in 2024-25 to over 57,000 for 2025-26, including 7,619 new approvals earlier. The MARB assesses institutions annually based on infrastructure, faculty (minimum 75% requirement per department), bed occupancy, and clinical load. Appeals provide a redressal mechanism, with the First Appeal Committee verifying claims like updated faculty appointments or infrastructure upgrades.

This follows similar actions, such as 187 additional seats cleared in late December 2025, reflecting NMC’s iterative approach to seat matrix finalization. Geographically, Tamil Nadu and Uttar Pradesh dominate the list, with institutions like SRM Medical College and Shaikh-UL-Hind Medical College benefiting. Northeast representation, via TRIHMS Arunachal Pradesh, highlights efforts to bolster regional healthcare training.

Public Health Implications

These 589 seats could train hundreds more specialists annually, addressing shortages in critical areas like general medicine (144 seats) and surgery (63 seats), where India needs over 25,000 additional doctors per NITI Aayog estimates. Enhanced anaesthesiology (109 seats) supports surgical volume, vital amid rising non-communicable diseases. For patients, this means potential improvements in access to quality care, especially in tier-2/3 cities hosting these colleges.

Aspiring PG candidates gain more options in the ongoing Round 1 counselling, reducing cut-offs in popular branches. Long-term, a larger specialist pool could lower healthcare costs and improve outcomes in public facilities, aligning with Ayushman Bharat goals.

Potential Limitations and Counterviews

Critics argue rapid expansions risk diluting quality if oversight lapses, citing past instances of faculty shortages or inadequate patient loads. The Indian Medical Association (IMA) has previously cautioned against “seat commercialization,” urging stricter post-admission audits. NMC mandates compliance verification before LOP issuance, but delays in formal permissions could cause counselling hiccups.

Some experts question concentration in private/deemed universities (e.g., 12 of 27), potentially favoring urban elites over public institutions. Nonetheless, the appeal process’s transparency—public lists and stakeholder notifications—mitigates concerns, with final LOPs ensuring accountability.

Practical Advice for Stakeholders

Medical graduates should monitor MCC updates for seat matrix revisions and prepare documents for choice-filling. Colleges must expedite compliance for LOPs to avoid future reversals. Patients and policymakers can view this as progress toward equitable specialist distribution, though sustained investment in faculty and infrastructure remains key.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References: